Patient Centricity as a Key Component for Successful Pharmacovigilance Strategies
The presentation was followed by a discussion with two patient advocates, one of whom has experienced the challenges of multimorbidity and polypharmacy, not unlike some of the personas and scenarios that form the basis for the Gravitate Health design. All agreed on the need for more “patient-friendly” health information, especially in situations where several drugs and diseases interact, leading to confusion and even conflicting information among the labels and leaflets currently provided.
“Patient Centricity as a Key Component for Successful Pharmacovigilance Strategies” session, consisting in two parts, provided a comprehensive overview of the importance of involving the patient to gather insights and sharp decision-making to enable the safe use of medicines. Speakers from industry and regulators provided Insights on this topic to highlight the importance of putting the patient at the center of what we do throughout the product’s lifecycle in relation to effective risk mitigation.
Raphael Elmadjian Pareschi, PharmD, MBA, Patient Safety Lead/ Head of Pharmacovigilance Brazil, Roche, Brazil and Bianca Passos, MBA, RPh, Country Safety Head – Brazil, Sanofi, Brazil chaired this session.
Speakers
Alan Hochberg, Principal Scientific Enablement Director, Scientific Enablement and Processes, Genentech, A Member of the Roche Group, United States; Gravitate Health Sustainability & Innovation Coordination Lead & WP7, Industry Co-lead
Kristof Vanfraechem, MSc, Founder and CEO, Data for Patients, Belgium
Christine Von Raesfeld, Founder/SME, Patient experience, People With Empathy, United States
Carolina Consuegra, MBA, Co-Founder Science to People, Colombia
